Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial. (Rees CA, Brousseau DC, Cohen DM, Villella A, Dampier C, Brown K, Campbell A, Chumpitazi CE, Airewele G, Chang T, Denton C, Ellison A, Thompson A, Ahmad F, Bakshi N, Coleman KD, Leibovich S, Leake D, Hatabah D, Wilkinson H, Robinson M, Casper TC, Vichinsky E, Morris CR, SCD Arginine Study Group and PECARN) Trials 2023 Aug 17;24(1):538 PMID: 37587492 PMCID: PMC10433602 SCOPUS ID: 2-s2.0-85168242874 08/17/2023 6 Citations
Return visit rates after an emergency department discharge for children with sickle cell pain episodes. (Coleman KD, McKinley K, Ellison AM, Alpern ER, Hariharan S, Topoz I, Wurtz M, Nielsen B, Cook LJ, Morris CR, Brandow AM, Campbell AD, Liem RI, Nuss R, Quinn CT, Thompson AA, Villella A, King AA, Baumann A, Frankenberger W, Brousseau DC) Pediatr Blood Cancer 2023 Oct;70(10):e30553 PMID: 37458568 PMCID: PMC11078470 SCOPUS ID: 2-s2.0-85165245395 07/17/2023 1 Citation
Five days of fever and myocardial inflammation. (Coleman KD, Benz P, Parikh NS, Thomas DG, Segar D, Block J, Schultz ML) SAGE Open Med Case Rep 2021;9:2050313X211050891 PMID: 34646566 PMCID: PMC8504640 SCOPUS ID: 2-s2.0-85116615830 10/15/2021